Advanced search

Karsten Munk Knudsen is Chief Financial Officer & Executive Vice President of Novo Nordisk A. In the past Mr. Knudsen occupied the position of Principal at A.P. Møller-Mærsk A, Head-Finance of NNIT A, VP-Finance & Information Technology at Novo Nordisk, Inc. and Financial Analyst at Nykredit Bank A. He received a graduate degree from the University of Aarhus.

Karsten Sivebæk Knudsen is currently the Vice Chairman at Nordsøenheden, Chairman at Polaris IV Invest Fonden, Chairman at VI Management P, Non-Independent Director & Co-MD at D, Director at Motortramp A, Director at Velliv, Pension & Livsforsikring A, Director at K, Director at K, Director at Obel-LFI Ejendomme A, Director at Aktieselskabet Dampskibsselskabet Orient's Fond, Managing Director & Director at Saga VII EUR K, Managing Director & Director at Saga VII USD K, Managing Director & Director at Saga VII USD PD AIV K, Managing Director & Director at Saga Viii Eur K, Managing Director & Director at Saga I-VII GP ApS, Director at A, Managing Director & Director at SAGA VII USD KS, and Director at K.
Formerly, Mr. Knudsen held the positions of Vice Chairman & Managing Director at Forstædernes Bank A from 2011 to 2012, Chairman at Nordic Trustee AS (Norway), Chairman at Centrica Energy Trading AS, Chairman at Ejendomsselskabet Kalvebod A, Group Managing Director at Nykredit A, Group Managing Director at Nykredit Realkredit.
A from 2009 to 2014, and had a position at Danske Markets, Inc.

Helge Karsten Knudsen worked as a Director at Sparebanken Møre from 1973 to 2012.

Marianne Munk worked as a Regional Manager at Immunodiagnostic Systems Nordic A.

Signe Munk worked as a Vice President of Toxicology and Regulatory Affairs at Novozymes A from 2013 to 2016.

Martin Munk has worked at Jyske Bank A since 2004.
His current job title is Equity Sales Vice President, which he started in 2016.

Zev Munk has a career history that includes founding positions and education.
He is the founder of MB Quest, Inc. (founded in 1997), Pharm-Olam LLC (founded in 1994), and Pharm-Olam International Ltd.
(founded in 1994).
At Pharm-Olam International Ltd., he holds the title of Chairman.
Dr. Munk obtained a doctorate degree from McGill University.